Analysed Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) News Sources
Vanda Pharmaceuticals Inc.: Vanda Announces FDA Grants Landmark Hearing for HETLIOZ in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years
FinanzNachrichten.de
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years
Le Lézard
Truist Securities initiates coverage of Vanda Pharmaceuticals (VNDA) with buy recommendation
Fintel on MSN
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
Markets Insider
AnaptysBio, Inc.: Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
FinanzNachrichten.de
What is the current price of Vanda Pharmaceuticals Inc. (VNDA:NASDAQ)?
The current price of Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) is $7.89.
Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) since the previous trading day is $-0.02.
Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) since the previous trading day is -0.25%.
What is This Week's average sentiment score for Vanda Pharmaceuticals Inc. (VNDA:NASDAQ)?
This Week's average sentiment score for Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) is 83 out of 100.
What is This Week's average sentiment for Vanda Pharmaceuticals Inc. (VNDA:NASDAQ)?
This Week's sentiment for Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.